From simply delicious water to healthy water. HOME SITE MAP Japanese
Nihon Trim Co.,Ltd. People,Life,Water Company Guide Research and Development Investor Relations
Japanese
Return to Research and Development
HOME >> Research and Development >> Nephron Clinical Practice Abstract of a paper published in April 2009
Related Infomation
Abstracts of Scientific Papers
PLOS ONE
(September 2017)
PLOS ONE
(February 2017)
Renal Replacement Therapy
(June 2016)
Environmental Control
In Biology
(July 2014)
Medical Gas Research
(December 2013)
Hemodial International
(November 2013)
PLoS ONE
(July 2012)
Cytotechnology
(June 2012)
Trends in Food Science and Technology
(November 2011)
BMC Proceedings
(November 2011)
BMC Proceedings
(November 2011)
Bioscience,
Biotechnology,
and Biochemistry
(July 2011)
Nephrology Dialysis Transplantation
(December 2010)
Cytotechnology
(November 2010)
Bioscience,
Biotechnology,
and Biochemistry
(October 2010)
Nephrology Dialysis Transplantation
(April 2010)
Nephrology Dialysis Transplantation
(February 2010)
Free Radical Research
(January 2010)
Nephron Clinical Practice
(April 2009)
Langmuir
(June 2008)
Biological & Pharmaceutical Bulletin
(January 2008)
Hemodialysis International
(June 2007)
Kidney International
(July 2006)
Cytotechnology
(January 2005)
Kidney International
Vol.64 (July 2003)
Cytotechnology
(June 2003)
BBRC
(BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS)
(May 1997)
List of Papers and Conference Presentations on Electrolyzed Reduced Water
What is electrolyzed reduced water?
Nephron Clinical Practice 2009;112:c9-c15 Abstract of paper published in April 2009
Biological effect of Electrolyzed Water in Hemodialysis
Background/Aims: The application of electrolyzed water (EW) at the cathode side to manufacture reverse osmosis (RO) water and hemodialysis (HD) solution can actually lead to less oxidative capacity in chemical terms. The present study examined the biological actions of this water on human polymorphonuclear leukocytes (PMNs), and the clinical feasibility of applying this technology to HD treatment.

Methods: RO water using EW (e-RO) exhibited less chemiluminescence in luminol-hydrogen peroxide and higher dissolved hydrogen levels (-99.0 ppb) compared with control RO water. The effects of e-RO on PMN viability were tested. HD using e-RO was performed for 12 consecutive sessions in 8 patients for the feasibility test.

Results: Basal cellular viability and function to generate superoxide radicals of PMNs were better preserved by e-RO application. In the clinical trial, reductions of blood pressure were noted, but no adverse events were observed. There were no changes in the blood dialysis parameters, although methylguanidine levels were significantly decreased at the end of study.

Conclusion: The present study demonstrated the capacity of e-RO to preserve the viability of PMNs, and the clinical feasibility of applying this water for HD treatment. The clinical application of this technology may improve the bio-compatibility of HD treatment.
Page Top
Nihon Trim Co.,Ltd.
Headquarters: 22nd Floor, Herbis Ent Office Tower, 2-2-22 Umeda, kita-ku, Osaka, 530-0001
Tel: +81-6-6456-4600 e-mail:info@nihon-trim.co.jp
Personal Information Protection Policy
Copyright 2006 Nihon Trim Co.,Ltd. All rights reserved. Unauthorized reproduction of illustrations, photographs,or trademarks on this Web site is prohibited.